Morgan Goldizen, FNP-BC
Family Nurse Practitioner in Altoona, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 210,832 in Family Nurse Practitioner, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Morgan Goldizen, FNP-BC filed 5,709 Medicare Part D claims in 2023 as a Family Nurse Practitioner in Altoona, Pennsylvania, prescribing 86% generic.
- 6K
- Part D claims, 2023
- 86%
- generic prescribing
- $699.48
- industry payments (Sunshine Act)
- ≥95th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1134890494 · Family Nurse Practitioner
NPI-10 · ENUM-RECENT · TAX-MEGA · RX-MID · BOOK-MID · PHOTO-ENUM
- NPI-10 1134890494
- ENUM-RECENT 2021
- TAX-MEGA 211K Family Nurse
- RX-MID 5,709
- BOOK-MID 6,508 in Pennsylvania
- PHOTO-ENUM Julee Kimball · 2021
Morgan Goldizen, FNP-BC's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
5,709 ≥ 95th percentile 95% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about Morgan Goldizen, FNP-BC?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Pennsylvania
How Family Nurse Practitioner compares to other specialties among Pennsylvania providers
Family Nurse Practitioner ranks #13 among Pennsylvania's specialties (2.5% of in-state providers)
Each bar is a specialty's share of the Pennsylvania provider total, by primary NUCC taxonomy. The highlighted bar is Family Nurse Practitioner; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Family Nurse Practitioner. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1134890494 |
|---|---|
| Specialty | Family Nurse Practitioner |
| Credentials | FNP-BC |
| Gender | Female |
| NPI Issued | 09/25/2021 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Morgan Goldizen, FNP-BC's current license status, disciplinary history, and board certifications with the Pennsylvania State Board of Medicine in Pennsylvania before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1134890494 is the unique 10-digit identifier CMS uses to link Goldizen across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Morgan Goldizen, FNP-BC bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Morgan Goldizen, FNP-BC. Source: openpaymentsdata.cms.gov.
Total received
$699
Largest payer
PFIZER INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Morgan Goldizen, FNP-BC. To verify Morgan Goldizen, FNP-BC's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
13% brand-name claims vs 86% generic, on 5,709 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 9,964
- Total Day Supply
- 291,196
- Brand vs Generic
- 13% brand / 86% generic
- Brand Drug Cost
- $509K
- Generic Drug Cost
- $94K
- Opioid Claims
- 168 (2.9% rate)
- Antibiotic Claims
- 62
Patient Demographics
- Average Patient Age
- 71.6 years
- Avg HCC Risk Score
- 1.17
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 88, 65-74: 199, 75-84: 121, 85+: 58
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Morgan Goldizen, FNP-BC prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
307 claims
- Lisinopril
Lisinopril
216 claims
- Pantoprazole Sodium
Pantoprazole Sodium
215 claims
- Levothyroxine Sodium
Levothyroxine Sodium
209 claims
- Metformin Hcl
Metformin Hcl
185 claims
- Amlodipine Besylate
Amlodipine Besylate
165 claims
- Omeprazole
Omeprazole
155 claims
- Gabapentin
Gabapentin
124 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 307 |
| Lisinopril | 216 |
| Pantoprazole Sodium | 215 |
| Levothyroxine Sodium | 209 |
| Metformin Hcl | 185 |
| Amlodipine Besylate | 165 |
| Omeprazole | 155 |
| Gabapentin | 124 |
| Furosemide | 111 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 103 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Nurse Practitioner Overview
How Morgan Goldizen, FNP-BC fits within the Family Nurse Practitioner landscape nationally.
Morgan Goldizen, FNP-BC's 5,709 claims are above the specialty average of 1,222.
Nationwide Family Nurse Practitioner peers with similar MIPS or enrollment year
Two federal-record peer sets for Goldizen, both outside Pennsylvania so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2021)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Family Nurse Practitioner Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Goldizen.
One of 6,508 Family Nurse Practitioner providers enrolled in Pennsylvania, 5 are shown here.
Compare Family Nurse Practitioner nationally: see state-by-state distribution →
Frequently Asked Questions
What is Morgan Goldizen, FNP-BC's specialty? ▼
How much does Morgan Goldizen, FNP-BC prescribe under Medicare Part D? ▼
Where is Morgan Goldizen, FNP-BC located? ▼
What is Morgan Goldizen, FNP-BC's NPI number? ▼
Does Morgan Goldizen, FNP-BC prescribe more brand-name or generic drugs? ▼
Does Morgan Goldizen, FNP-BC prescribe opioids? ▼
How many Family Nurse Practitioner providers are there in the US? ▼
What drugs does Morgan Goldizen, FNP-BC prescribe most often? ▼
Does Morgan Goldizen, FNP-BC accept Medicare? ▼
How can I verify Morgan Goldizen, FNP-BC's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.